TY - CHAP
T1 - Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel
AU - Nagy, Istvan
AU - Friston, Dominic
AU - Valente, João Sousa
AU - Perez, Jose Vicente Torres
AU - Andreou, Anna P.
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2014
Y1 - 2014
N2 - The capsaicin receptor, transient receptor potential vanilloid type 1 ion channel (TRPV1), has been identified as a polymodal transducer molecule on a sub-set of primary sensory neurons which responds to various stimuli including noxious heat (>~42 °C), protons and vanilloids such as capsaicin, the hot ingredient of chilli peppers. Subsequently, TRPV1 has been found indispensable for the development of burning pain and reflex hyperactivity associated with inflammation of peripheral tissues and viscera, respectively. Therefore, TRPV1 is regarded as a major target for the development of novel agents for the control of pain and visceral hyperreflexia in inflammatory conditions. Initial efforts to introduce agents acting on TRPV1 into clinics have been hampered by unexpected side-effects due to wider than expected expression in various tissues, as well as by the complex pharmacology, of TRPV1. However, it is believed that better understanding of the pharmacological properties of TRPV1 and specific targeting of tissues may eventually lead to the development of clinically useful agents. In order to assist better understanding of TRPV1 pharmacology, here we are giving a comprehensive account on the activation and inactivation mechanisms and the structure-function relationship of TRPV1.
AB - The capsaicin receptor, transient receptor potential vanilloid type 1 ion channel (TRPV1), has been identified as a polymodal transducer molecule on a sub-set of primary sensory neurons which responds to various stimuli including noxious heat (>~42 °C), protons and vanilloids such as capsaicin, the hot ingredient of chilli peppers. Subsequently, TRPV1 has been found indispensable for the development of burning pain and reflex hyperactivity associated with inflammation of peripheral tissues and viscera, respectively. Therefore, TRPV1 is regarded as a major target for the development of novel agents for the control of pain and visceral hyperreflexia in inflammatory conditions. Initial efforts to introduce agents acting on TRPV1 into clinics have been hampered by unexpected side-effects due to wider than expected expression in various tissues, as well as by the complex pharmacology, of TRPV1. However, it is believed that better understanding of the pharmacological properties of TRPV1 and specific targeting of tissues may eventually lead to the development of clinically useful agents. In order to assist better understanding of TRPV1 pharmacology, here we are giving a comprehensive account on the activation and inactivation mechanisms and the structure-function relationship of TRPV1.
UR - http://www.scopus.com/inward/record.url?scp=84901194844&partnerID=8YFLogxK
U2 - 10.1007/978-3-0348-0828-6_2
DO - 10.1007/978-3-0348-0828-6_2
M3 - Chapter
C2 - 24941664
AN - SCOPUS:84901194844
SN - 9783034808279
T3 - Progress in Drug Research
SP - 39
EP - 76
BT - Capsaicin as a Therapeutic Molecule
PB - Birkhauser Verlag AG
ER -